New hope for neuro-sufferers

Gordon McCauley, CEO and President of Allon Therapeutics, discusses the important quest for an effective drug combating neuro-degenerative diseases, and the successes developing their drug davunetide [8m 08secs]

Gordon McCauley, CEO and President of Allon Therapeutics, discusses the important quest for an effective drug combating neuro-degenerative diseases, and the successes developing their drug davunetide [8m 08secs]

mccauley-video